And then there were four.
Late Thursday the FDA announced that it had approved edoxaban, the new oral anticoagulant manufactured by Daiichi Sankyo. The drug will be marketed under the brand name of Savaysa and joins three other new drugs in the large and important new oral anticoagulant marketplace…
…
Click here to read the full post on Forbes, including a comment from Sanjay Kaul.
Reblogged this on dabingar and commented:
edoxaban